Guardant Health Inc (GH) Stock Price, Quote & News

Company Profile

Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, and data sets in the United States and internationally. The company offers Guardant360 CDx test, a liquid biopsy test for tumor mutation profiling; Guardant360 Liquid test, which measures 740+ genes and supports all guideline-recommended biomarkers; Guardant Reveal test, a blood test that utilizes circulating tumor DNA to detect cancer at the molecular level; and Guardant360 Tissue test, a molecular profiling t...

Industry: Diagnostics & Research

Sector: Healthcare

Phone: 855 698 8887

Fax: 888 974 4258

Website: guardanthealth.com

Address:

3100 Hanover Street, Palo Alto, United States

Gator5326 Mar. 18 at 1:41 PM

$GH https://u18966101.ct.sendgrid.net/ls/click?upn=u001.4ITdg8fiPHHXRRODKhpNknNKs0V2h8ItR6Q2oQCQKcTyRrxC8ZerlixSyXRNZh4ketL7E2RWkAerRsZCr7TPZyHSCsppSPtyeGddfxO4qyf7-2BfqgDTPA1pwQgPEK0LIA243hJjC5CJS5rkv-2BozOxXBePAmNpgvmD2zSIApV6gJ-2FPLfFEX4Jc6UIOQBfrESlGtEwydSrbIiNt88leefix3K8D4UASyvPWJP5vjPye672AlZt9btC4vUDJoJyoN6BW67a9vyLxJ7a6k8Ru0pob6nxKoAb27-2BU3uxZA0-2BHiMTTTNrBci2y0msV8Gvp4ZjA43GlK4cz4404WcE-2Fiqo5vQT29Ibl4IX4BDZDlB-2FyliPw-3DuU7r_n7gaS9t6bMxECCQWPRdwdqPZyOAjF4RSivuNxLLPR-2FSmysoqQW1ClVyewMaUHyr5PXnLg-2BfGbSor9w1GLElWTiEw3tZro1MLP1IzWdS5qPpbfYGAtnJcrhAqCrHeCZaHRgIG36Opi-2BfPD0wkS0BpMqfk4NRY1V1Yir-2FJgxEvDALy2fSjAZwWCPrIQ8X8PbJcKyuDR5U5EMC8ks3MmhdRfOafhQ-2B4cplgmpKZV0Cc8X2Yr488iDprCnDbljpWtoaggKV6b1Ke3Tar-2BwiUl16hirqZ2W8zttFq-2FMdgK4aTI-2FWgyoNmmZ6gzg9JhqvJQRgzUh6ZV7Rc9EVKWh9u8-2FApCaaza-2Fpdwm0QlGlB6gAVxzptm9zUxzhlM3r1NYi-2Fabc40E6Timl0hqHDGmfqzqTq-2BFZEO3wFvITK7u6UI8VJ-2BZInUs82fpl-2Bc7mJIL-2FfH9HB3aTI8GGFXXAfGyt0HWDiRE67GbO9-2BmS0MCLGv4f4tRPvSum-2B9ROZ-2FnXx8GnLDeOQM0UyNMLSGvdWLB9cas-2FiWg-3D-3D

0 · Reply

Cutlass Mar. 16 at 1:19 PM

$GH Been dropping for 8 weeks now - Will wait, on watch 👀

1 · Reply

Gator5326 Mar. 16 at 1:03 PM

$GH How awesome is $GH? “By being the first insurer in Asia to offer the Shield MCD test, we’re empowering our customers with a credible and valued service that encourages proactive health management,” said Steve Finch, President and CEO of Manulife Asia. “This exclusive partnership demonstrates our commitment to offering innovative and differentiated solutions to improve the health outcomes of our customers.”

0 · Reply

Gator5326 Mar. 16 at 12:14 PM

$GH https://u18966101.ct.sendgrid.net/ls/click?upn=u001.4ITdg8fiPHHXRRODKhpNknNKs0V2h8ItR6Q2oQCQKcTyRrxC8ZerlixSyXRNZh4ketL7E2RWkAerRsZCr7TPZyHSCsppSPtyeGddfxO4qyf7-2BfqgDTPA1pwQgPEK0LIA8n6vjeFh7ltQM-2FMG941fInP13SAcMpRo6VDsnUg7wblttRy5hVbEExlnHG1xLYP4F7XhCPe6vj6Eqx3RMAN8lvT6sMgbaDJim-2FJ3hpO8MVblQwC-2F75wUn30yHteYUQZgaJ4DtTX6zbkXHC3G7fHjipE0KJW26gDHiuKCoNregYQ-3DeWLb_n7gaS9t6bMxECCQWPRdwdqPZyOAjF4RSivuNxLLPR-2FSmysoqQW1ClVyewMaUHyr5PXnLg-2BfGbSor9w1GLElWTiEw3tZro1MLP1IzWdS5qPpbfYGAtnJcrhAqCrHeCZaHRgIG36Opi-2BfPD0wkS0BpMi-2FR4SgqcBs7yQ0n-2F4ewtV-2FoySDDLHo55fynoKdW-2FF8L2AP41DZU8YxMc5jJngulijGCo4ufujXTXqs5zQKf4ABhdVsaTKWqDj2U5u8B22GvnAbXECVsb1d83ip4se7iRxEJtoiX2-2BboDSJBtwMZFkNQltlxB-2BWzVnSvuaVshJIo5kjCu-2B56EiFHir6kWZnVOWGKCzgn-2BqVgLNFvO4D5sNUdlsSvfeQMWNEj2m2HqKE7qwgL9cbAux-2FmHOnDZ8f5xMnx2nD5XsA7L0ds8lR997EJ4rWV-2B8tmz6fIu6ByIgTSJYjR12gWVthfvjNbg2Mrog-3D-3D

0 · Reply

Gator5326 Mar. 13 at 8:41 PM

$GH https://m.facebook.com/story.php?story_fbid=pfbid02F7c781W1Cpy6zKY8ko9Lm7DPSGHhmSJ4Lb6wi7bD9f74GtC4dNbPCbDL4QARferhl&id=100044244079017

0 · Reply

Gator5326 Mar. 13 at 12:12 PM

$GH https://u18966101.ct.sendgrid.net/ls/click?upn=u001.4ITdg8fiPHHXRRODKhpNknNKs0V2h8ItR6Q2oQCQKcTyRrxC8ZerlixSyXRNZh4ketL7E2RWkAerRsZCr7TPZyHSCsppSPtyeGddfxO4qyc0ykOikWEhSXYW21xyo5BdQN35uOTs4e7SRVbKJrb8qqHmK9yVCU4R4OX1GhDmqkgXZjS9ywBPtvYt16xmVBD5MGzzYjyqIpDxYb0sUmINArAMnFB0IodpoXW5FulLy4r6l1iBKWaS02pM-2BE25dJYkXwvcZQYJH6yVqoCCen0dqjbJdX2H-2B3X8AXCiWBB1xNeZDRUmNAwpQf1a4VGFycve-2Few3HjlyzHNvUu0WzNQXRjSnNoVaE7n1KD-2FqdWwUDkY-3DI3Hf_n7gaS9t6bMxECCQWPRdwdqPZyOAjF4RSivuNxLLPR-2FSmysoqQW1ClVyewMaUHyr5PXnLg-2BfGbSor9w1GLElWTiEw3tZro1MLP1IzWdS5qPpbfYGAtnJcrhAqCrHeCZaHRaWxdbhNYu4J6vtCfFut8RKM6aMY3xxO09R1HfVxhAsH6qUmo2jAgLi2Ejzky02-2B1-2Bfdy82ibTWoWWv7E-2Fp9obLiSHe8Txnezpfe7ekSBSyKlVN-2BkbNa2njSnruPZEKDbhxqK-2Bw-2FRaEt9ycuFNtEI9diHACLr9vnOHwaUwIv16MScV38nmCgrjN4mcrKgdjhRDXpRjIDI1Z159HuckffsGXfjMhesMS2aysuTBl-2BSN3R5qmzS9kZhmY2hFnnc9Zs-2BA0wyTdQ24X9qagOAtguWkVkFxs2OdL-2B4tIU67i5oazXFcVyySaLHifdCUZ4JFwbaqk-2BHyFmVc4IsU3urJV0ToEotL8wON3JUzs5a3EtI5x-2FBVdxij91kMYAbt3j9ppzhAVdoumd8Hh8F-2B16I0JvgQ-3D-3D

1 · Reply

123rs123 Mar. 13 at 8:03 AM

$GH market gifted us with an insane discount, instabuy at these levels

1 · Reply

GoldenBum77 Mar. 12 at 5:08 PM

$GH Can anyone explain how this went from $120 to $83 on only good news?

1 · Reply

_TP888 Mar. 12 at 4:44 PM

$GH | $80.00 | Put | Premium: $1.05M Ask-heavy - aggressive put buyers.

0 · Reply

thingkfast Mar. 11 at 11:56 PM

$GH gap fill?

1 · Reply

Guardant Health to Present 28 Abstracts Highlighting Advances in Tumor Typing, Therapy Selection and Expanded Utility of Multiomic Tissue and Liquid Biopsy Testing at AACR 2026

Mar 16, 2026, 10:04 AM EDT - 5 days ago

Invesco Small Cap Equity Fund Q4 2025 Portfolio Review

ATI AVAV BE BTSG CVLT ECG FRMI

Mar 16, 2026, 8:05 AM EDT - 5 days ago

Guardant Health Launches Shield Multi-Cancer Detection (MCD) Test in Multiple Markets in Asia with Manulife Partnership

Mar 13, 2026, 8:05 AM EDT - 8 days ago

New Guardant Health/Harris Poll Survey Shows 92% of All Eligible Americans Believe Colorectal Cancer Blood Tests Should be Accessible and Covered Similar to Medicare

Mar 12, 2026, 12:49 PM EDT - 9 days ago

Invesco Main Street Mid Cap Fund Q4 2025 Portfolio Activity

ALAB ASND ATI BLSH BRBR CACI CG

Mar 11, 2026, 3:32 PM EDT - 10 days ago

Guardant Health, Inc. (GH) Presents at Barclays 28th Annual Global Healthcare Conference Transcript

Mar 10, 2026, 8:05 AM EDT - 11 days ago

Guardant Health's Shield Blood-based Screening Test for Colorectal Cancer Now Accessible Through National Test Ordering and Collection Network of Quest Diagnostics

Mar 4, 2026, 7:00 AM EST - 17 days ago

Guardant Health Launches Coast-to-Coast Screening Tour, Bringing Shield Colon Cancer Blood Test to Over 100 Communities Across America

Mar 3, 2026, 7:00 AM EST - 18 days ago

Actor and Cancer Advocate Patrick Dempsey Partners with Guardant Health to Raise Awareness about Colorectal Cancer Screening and Shield Blood Test, Sharing His Experience Getting Screened

Mar 2, 2026, 2:28 PM EST - 19 days ago

Carillon Eagle Small Cap Growth Fund Q4 2025 Portfolio Review

BE BTSG COHR ESTA HIMS ITRI PRKS

Feb 27, 2026, 4:05 PM EST - 22 days ago

Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Feb 26, 2026, 7:05 PM EST - 22 days ago

Allspring Smid Cap Growth Fund Q4 2025 Top Contributors And Detractors

ATI BE CRS CVLT NTRA TEVA TLN

Feb 20, 2026, 12:45 AM EST - 4 weeks ago

Allspring Mid Cap Growth Fund Q4 2025 Performance Insights, Portfolio Drivers & Decisions

CRS CVLT DASH HOOD NTRA TEVA VIK

Feb 19, 2026, 8:14 PM EST - 4 weeks ago

Guardant Health, Inc. (GH) Q4 2025 Earnings Call Transcript

Feb 19, 2026, 4:05 PM EST - 4 weeks ago

Guardant Health Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Outlook

Feb 12, 2026, 2:35 PM EST - 5 weeks ago

Guardant Health Launches Community Colorectal Cancer Screening Grant Program in Recognition of CRC Awareness Month, Applications Now Open

Feb 3, 2026, 4:05 PM EST - 6 weeks ago

Guardant Health to Participate in Upcoming Investor Conferences

Feb 2, 2026, 8:05 AM EST - 6 weeks ago

Largest Published Study of Molecular Residual Disease (MRD) in Stage III Colon Cancer Shows Guardant Reveal Blood Test More Precisely Identifies Risk of Recurrence After Surgery to Support Timely Treatment Decisions

Jan 29, 2026, 4:05 PM EST - 7 weeks ago

Guardant Health to Report Fourth Quarter and Full Year 2025 Financial Results on February 19, 2026

Jan 29, 2026, 1:22 PM EST - 7 weeks ago

Alger Small Cap Focus Fund Q4 2025 Portfolio Update

EXAS NBIS NTRA QURE STVN

Jan 26, 2026, 9:31 AM EST - 7 weeks ago

Guardant Health: Look For Explosive Revenue Growth Ahead

Jan 26, 2026, 3:54 AM EST - 7 weeks ago

Alger Small Cap Growth Fund Q4 2025 Portfolio Update

EXAS NBIS NTRA RZLT WIX

Jan 23, 2026, 9:08 AM EST - 2 months ago

Artisan Small Cap Fund Q4 2025 Portfolio Activity

BRKR CLBT FLEX HXL INSM IRTC ITGR

Jan 22, 2026, 12:51 PM EST - 2 months ago

FDA Approves Guardant Health's Blood Test To Guide Treatment For Advanced Colorectal Cancer

Jan 22, 2026, 8:05 AM EST - 2 months ago

Guardant Health Receives FDA Approval for Guardant360® CDx as Companion Diagnostic for BRAFTOVI® (encorafenib) Combination in Patients with BRAF V600E-Mutant Metastatic Colorectal Cancer

Jan 22, 2026, 5:15 AM EST - 2 months ago

Alger Mid Cap Focus Fund Q4 2025 Portfolio Update

EXAS HOOD NBIS NTRA RBLX

Jan 19, 2026, 8:05 AM EST - 2 months ago

Guardant Health Announces Multi-Year Strategic Collaboration Agreement with Merck to Develop Companion Diagnostics and Commercialize New Cancer Therapies Using Guardant Infinity Smart Platform

Jan 18, 2026, 4:32 AM EST - 2 months ago

Guardant Health: Shield Colorectal Cancer Screening To Sustain Growth

Jan 12, 2026, 10:15 PM EST - 2 months ago

Guardant Health, Inc. (GH) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Jan 11, 2026, 5:00 PM EST - 2 months ago

Guardant Health Announces Preliminary Fourth Quarter and Full Year 2025 Results

Jan 8, 2026, 8:05 AM EST - 2 months ago

Guardant Health's Shield Blood Test for Colorectal Cancer Screening Now Available for U.S. Military Members and Families

Dec 29, 2025, 4:05 PM EST - 2 months ago

Guardant Health to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Dec 29, 2025, 10:10 AM EST - 2 months ago

Global Healthy Living Foundation and Guardant Health Announce Partnership to Advance Awareness of Early Colorectal Cancer Detection and Improve Access to Screening

Dec 24, 2025, 8:30 AM EST - 3 months ago

Where To Invest In 2026: Top 5 Secular Growth Trends

AMPX CHYM LSCC MOD PRCT

Dec 11, 2025, 8:05 AM EST - 3 months ago

Guardant Health Announces Collaboration with Trial Library to Increase Access to Cancer Clinical Trials Across the U.S.

Dec 9, 2025, 8:05 AM EST - 3 months ago

Guardant Health and Policlinico Gemelli Launch In-House Liquid Biopsy Testing Service in Italy

Dec 5, 2025, 8:05 AM EST - 3 months ago

Guardant Health to Present 14 Abstracts Demonstrating the Power of Multiomic Liquid Biopsy Tests in Predicting Outcomes and Tailoring Treatment for Early and Metastatic Breast Cancer at the 2025 San Antonio Breast Cancer Symposium

Dec 2, 2025, 7:23 PM EST - 3 months ago

Senator Buys Coca-Cola, Hershey's Stock After Selling Magnificent Seven Stocks In 2025

HSY KO

Nov 28, 2025, 11:47 AM EST - 4 months ago

5 Top Stocks For AI Fatigue

AMBP GSL OHI PARR

Nov 20, 2025, 3:45 PM EST - 4 months ago

These 15 stocks are still showing momentum — and a market-beating edge

BE CIEN CRDO INSM LITE MP MU

Nov 18, 2025, 12:59 PM EST - 4 months ago

6 Healthcare Stocks With Strong Upward Momentum

ABVX CAH ELAN MEDP WGS

Nov 12, 2025, 8:05 AM EST - 4 months ago

Guardant Health Announces Launch of Single Namespace Group Uniting Leading Technology, Healthcare and Research Institutions to Set Global Standard for Exabyte-Scale Data Access

Nov 10, 2025, 8:05 AM EST - 4 months ago

Guardant Health Expands Tissue-Free Reveal Test to Include Late-Stage Therapy Response Monitoring

Nov 6, 2025, 8:05 AM EST - 4 months ago

New Study Validates Guardant Reveal Blood Test's Effectiveness in Monitoring Chemotherapy Response

Nov 5, 2025, 4:05 PM EST - 4 months ago

Shield CRC Blood Test Demonstrates Adherence of 95% in New Study of 20,000 Patients

Nov 5, 2025, 2:15 AM EST - 4 months ago

Guardant Health Prices Upsized $350.0 Million Convertible Senior Notes Offering

Nov 5, 2025, 2:15 AM EST - 4 months ago

Guardant Health Announces Pricing of Upsized Public Offering of Common Stock

Nov 4, 2025, 4:39 PM EST - 4 months ago

Guardant Health Announces Proposed Public Offering of Common Stock

Nov 4, 2025, 4:38 PM EST - 4 months ago

Guardant Health Announces Proposed $300.0 Million Offering of Convertible Senior Notes Due 2033

Oct 31, 2025, 11:09 AM EDT - 5 months ago

Guardant Health Beats Expectations: Shield, Quest, And AI Catalysts

Gator5326 Mar. 18 at 1:41 PM

0 · Reply

Cutlass Mar. 16 at 1:19 PM

$GH Been dropping for 8 weeks now - Will wait, on watch 👀

1 · Reply

Gator5326 Mar. 16 at 1:03 PM

0 · Reply

Gator5326 Mar. 16 at 12:14 PM

$GH https://u18966101.ct.sendgrid.net/ls/click?upn=u001.4ITdg8fiPHHXRRODKhpNknNKs0V2h8ItR6Q2oQCQKcTyRrxC8ZerlixSyXRNZh4ketL7E2RWkAerRsZCr7TPZyHSCsppSPtyeGddfxO4qyf7-2BfqgDTPA1pwQgPEK0LIA8n6vjeFh7ltQM-2FMG941fInP13SAcMpRo6VDsnUg7wblttRy5hVbEExlnHG1xLYP4F7XhCPe6vj6Eqx3RMAN8lvT6sMgbaDJim-2FJ3hpO8MVblQwC-2F75wUn30yHteYUQZgaJ4DtTX6zbkXHC3G7fHjipE0KJW26gDHiuKCoNregYQ-3DeWLb_n7gaS9t6bMxECCQWPRdwdqPZyOAjF4RSivuNxLLPR-2FSmysoqQW1ClVyewMaUHyr5PXnLg-2BfGbSor9w1GLElWTiEw3tZro1MLP1IzWdS5qPpbfYGAtnJcrhAqCrHeCZaHRgIG36Opi-2BfPD0wkS0BpMi-2FR4SgqcBs7yQ0n-2F4ewtV-2FoySDDLHo55fynoKdW-2FF8L2AP41DZU8YxMc5jJngulijGCo4ufujXTXqs5zQKf4ABhdVsaTKWqDj2U5u8B22GvnAbXECVsb1d83ip4se7iRxEJtoiX2-2BboDSJBtwMZFkNQltlxB-2BWzVnSvuaVshJIo5kjCu-2B56EiFHir6kWZnVOWGKCzgn-2BqVgLNFvO4D5sNUdlsSvfeQMWNEj2m2HqKE7qwgL9cbAux-2FmHOnDZ8f5xMnx2nD5XsA7L0ds8lR997EJ4rWV-2B8tmz6fIu6ByIgTSJYjR12gWVthfvjNbg2Mrog-3D-3D

0 · Reply

Gator5326 Mar. 13 at 8:41 PM

$GH https://m.facebook.com/story.php?story_fbid=pfbid02F7c781W1Cpy6zKY8ko9Lm7DPSGHhmSJ4Lb6wi7bD9f74GtC4dNbPCbDL4QARferhl&id=100044244079017

0 · Reply

Gator5326 Mar. 13 at 12:12 PM

$GH https://u18966101.ct.sendgrid.net/ls/click?upn=u001.4ITdg8fiPHHXRRODKhpNknNKs0V2h8ItR6Q2oQCQKcTyRrxC8ZerlixSyXRNZh4ketL7E2RWkAerRsZCr7TPZyHSCsppSPtyeGddfxO4qyc0ykOikWEhSXYW21xyo5BdQN35uOTs4e7SRVbKJrb8qqHmK9yVCU4R4OX1GhDmqkgXZjS9ywBPtvYt16xmVBD5MGzzYjyqIpDxYb0sUmINArAMnFB0IodpoXW5FulLy4r6l1iBKWaS02pM-2BE25dJYkXwvcZQYJH6yVqoCCen0dqjbJdX2H-2B3X8AXCiWBB1xNeZDRUmNAwpQf1a4VGFycve-2Few3HjlyzHNvUu0WzNQXRjSnNoVaE7n1KD-2FqdWwUDkY-3DI3Hf_n7gaS9t6bMxECCQWPRdwdqPZyOAjF4RSivuNxLLPR-2FSmysoqQW1ClVyewMaUHyr5PXnLg-2BfGbSor9w1GLElWTiEw3tZro1MLP1IzWdS5qPpbfYGAtnJcrhAqCrHeCZaHRaWxdbhNYu4J6vtCfFut8RKM6aMY3xxO09R1HfVxhAsH6qUmo2jAgLi2Ejzky02-2B1-2Bfdy82ibTWoWWv7E-2Fp9obLiSHe8Txnezpfe7ekSBSyKlVN-2BkbNa2njSnruPZEKDbhxqK-2Bw-2FRaEt9ycuFNtEI9diHACLr9vnOHwaUwIv16MScV38nmCgrjN4mcrKgdjhRDXpRjIDI1Z159HuckffsGXfjMhesMS2aysuTBl-2BSN3R5qmzS9kZhmY2hFnnc9Zs-2BA0wyTdQ24X9qagOAtguWkVkFxs2OdL-2B4tIU67i5oazXFcVyySaLHifdCUZ4JFwbaqk-2BHyFmVc4IsU3urJV0ToEotL8wON3JUzs5a3EtI5x-2FBVdxij91kMYAbt3j9ppzhAVdoumd8Hh8F-2B16I0JvgQ-3D-3D

1 · Reply

123rs123 Mar. 13 at 8:03 AM

$GH market gifted us with an insane discount, instabuy at these levels

1 · Reply

GoldenBum77 Mar. 12 at 5:08 PM

$GH Can anyone explain how this went from $120 to $83 on only good news?

1 · Reply

_TP888 Mar. 12 at 4:44 PM

$GH | $80.00 | Put | Premium: $1.05M Ask-heavy - aggressive put buyers.

0 · Reply

thingkfast Mar. 11 at 11:56 PM

$GH gap fill?

1 · Reply

Gator5326 Mar. 11 at 5:55 PM

$GH ACS fireworks coming soon!

0 · Reply

Gator5326 Mar. 10 at 5:33 PM

$GH Another great call. 2026 and beyond! $GH firing on all cylinders! 😎

0 · Reply

Gator5326 Mar. 10 at 1:11 PM

$GH 3 years ago I asked my GP if he heard of $GH during my yearly. He had not. Last year I asked him again and he said yes, it was third option 1. Colonoscopy 2. Cologuard 3. Shield. I can’t wait to ask him this year, lol.

1 · Reply

Gator5326 Mar. 10 at 12:34 PM

$GH https://u18966101.ct.sendgrid.net/ls/click?upn=u001.4ITdg8fiPHHXRRODKhpNknNKs0V2h8ItR6Q2oQCQKcTyRrxC8ZerlixSyXRNZh4ketL7E2RWkAerRsZCr7TPZyHSCsppSPtyeGddfxO4qyf7-2BfqgDTPA1pwQgPEK0LIAEdU5tJ99oTUxybcxc4sOAbM9AyQjFo2c-2BTr2ia50GjKmPPYxomUe1b7ucKEJOL-2BuAfDncFXAjkSR8y7b4y4oGCMigQjyE99n-2BhsipciN-2BdexjVR4G0ECvhcASCRcDRb43LnWHvUplTY2oU4Wf0X8We2Megou0mDfisvASfWGiRJ3sJkmfDPU3VugDysotRVWdk8Rx434dGlOqTpnyEKXGtwd2kknPxm206PNWYMvdqA-3DKeKO_n7gaS9t6bMxECCQWPRdwdqPZyOAjF4RSivuNxLLPR-2FSmysoqQW1ClVyewMaUHyr5PXnLg-2BfGbSor9w1GLElWTiEw3tZro1MLP1IzWdS5qPpbfYGAtnJcrhAqCrHeCZaHRgIG36Opi-2BfPD0wkS0BpMlqn-2Fk-2FrM2GYqDRMerLL-2F95FJmGGB9VrBIZamHiBbTuGHTK6j4AgnYmGyqHxllQ9W8H5dcnwrQxgcdMhc5gXVdV8J5lSTb56UOGzIyCVqngeoEairXH145U7cBA0aT5BHkphVMEPKxyXVjqkpjCxkG08lA3nNiHrb2IKtCG326F8hok2G8t6xOkhdaSDmZP5TnOjDsr4gAsFEF7n-2BCa5NkSmUbNBKaFAI2jqY30KIgNbCmVFNfQmHcZOs-2FyNjnbxGegzJFAEAx-2BwPXGAho-2BFDH96riA9Tl8DJLPBg4t8BEYgzv-2BE4Fx7XzddnV-2BSUzK67WbWth2xoublLAn4eKxML3P-2BSVRTogXqEzU8Urv5aQKTckiDnpOSMQA2cPJk8mTpCw-3D-3D

0 · Reply

ZacksResearch Mar. 5 at 5:10 PM

$GH vs $BIAF: Why Guardant Health Looks More Compelling Now! 📈 📊 GH surged 131.6% in the past year, while BIAF plunged 90.9%! 🧬 GH's strategic collaborations and expanding product portfolio drive its strong market position. 💰 BIAF trades at a deep discount relative to its historical range and the broader medical sector but faces growth uncertainty despite promising tech. Find out why GH is the preferred pick 👉 https://www.zacks.com/stock/news/2879579/biaf-vs-gh-which-cancer-detection-stock-is-the-better-buy-now?cid=sm-stocktwits-2-2879579-body-36157&ADID=SYND_STOCKTWITS_TWEET_2_2879579_BODY_36157

0 · Reply

ZacksResearch Mar. 5 at 4:10 PM

$BIAF vs. $GH — two cancer detection plays, two very different strategies. Which one has the edge right now? 👀 bioAffinity is leaning on its CyPath Lung sputum test for early lung cancer detection, while Guardant Health is expanding across liquid biopsy and screening. Focused niche vs. broader platform — that’s the real debate. Which model wins from here? Full head-to-head breakdown 👉 https://www.zacks.com/stock/news/2879579/biaf-vs-gh-which-cancer-detection-stock-is-the-better-buy-now?cid=sm-stocktwits-2-2879579-teaser-36148&ADID=SYND_STOCKTWITS_TWEET_2_2879579_TEASER_36148

0 · Reply

BillionerOfKing Mar. 4 at 6:48 PM

$GH Current Stock Price: $94.46 Contracts to trade: $95.0 GH Mar 20 2026 Call Entry: $4.20 Exit: $8.04 ROI: 91% Hold ~29 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

Gator5326 Mar. 4 at 12:40 PM

$GH The life changing blood test is hitting the road! https://u18966101.ct.sendgrid.net/ls/click?upn=u001.4ITdg8fiPHHXRRODKhpNknNKs0V2h8ItR6Q2oQCQKcTyRrxC8ZerlixSyXRNZh4ketL7E2RWkAerRsZCr7TPZyHSCsppSPtyeGddfxO4qyf7-2BfqgDTPA1pwQgPEK0LIAgqhDD8V3BueGRIC1Xdy0LPaSZUGPwxugQ7hM-2FJ6YYEJTD6SIPCrnX-2B56l-2BGginPZDjIjEUkU3tAxdjZ34Tl6QS1zKieevMZiNOT3TYzndjoS7ePyjDhKk9KUcFm8rkfC28vFI8vGkv-2FQrfCcpi6laHVJ5zerP0BUDKNHKd6A4b2JhiukTdh2thhjktXV4Wk39Ke-_n7gaS9t6bMxECCQWPRdwdqPZyOAjF4RSivuNxLLPR-2FSmysoqQW1ClVyewMaUHyr5PXnLg-2BfGbSor9w1GLElWTiEw3tZro1MLP1IzWdS5qPpbfYGAtnJcrhAqCrHeCZaHRgIG36Opi-2BfPD0wkS0BpMiv-2B389NpYl8Q7dFQBOwtJP-2By8CsWZiNvJR0fyQuSktTEi0029lm9qIVaumvVjZcuKRi28IS-2BD-2BpntUpbQhBYZ7zOQ2Qkvf0A0T3vRV-2FlVK3KW8u38D2Chp2i9w-2B12zjjVrOeazahFPdcyTn9GMsk3yDkRXWk4QgcZ0PzM3N8NQhZ2CYUwufZHTw1qPcTqb2sxvarm00ZIcR-2Fixt0dLOM-2B8FnDRlU0zpUz8JqGZsHcG00A-2Fmt6-2BpkgjwCMJwgzB2mx3oOCOPsP3TOvkFrgJ-2BOj9qZZZ3xyG2dj7ody75NSxCxHdpBPy8wxQ0Ns67ukPZtYtDRxWsQLmCbj7hiTtXdXo-3D

0 · Reply

Gator5326 Mar. 4 at 11:39 AM

$GH $GH on CBS https://www.cbsnews.com/video/patrick-dempsey-advocates-for-colorectal-cancer-awareness-and-talks-friendship-with-eric-dane/

0 · Reply

JasonCO Mar. 3 at 8:21 PM

$GH nice move from $88. Send it

0 · Reply

WallStJesus Mar. 3 at 7:16 PM

$GH UNUSUAL BUYER DETECTED IN THE HEALTHCARE PLAY

0 · Reply

Gator5326 Mar. 3 at 7:07 PM

$GH https://m.facebook.com/story.php?story_fbid=pfbid02bYy3Ri5Vp1BZeZy1vfGctnapUpTEs2UGoQvocs9L4eeP1VP2cptPjqqDowtwozppl&id=61579040902416

0 · Reply

Market Cap	11.45B
Revenue (ttm)	982.02M
Net Income (ttm)	-416.28M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-42.39%
Debt to Equity Ratio	-15.14

Volume	2,401,200
Avg Vol	1,959,598
Day's Range	N/A - N/A
Shares Out	131.17M
Stochastic %K	28%
Beta	1.67
Analysts	Strong Sell
Price Target	$134.50